NYU LANGONE HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
UB-312 in Patients With Synucleinopathies
Phase 1
Active, not recruiting
- Conditions
- Parkinson DiseaseMultiple System Atrophy
- Interventions
- Biological: UB-312 InjectionBiological: Placebo Injection
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 8
- Registration Number
- NCT05634876
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Study of the Aliviado DSD Caregiving Mastery Program
Not Applicable
Completed
- Conditions
- Delirium Superimposed on Dementia
- Interventions
- Behavioral: Aliviado DSD Caregiving Mastery Program
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 33
- Registration Number
- NCT05630014
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
MAGIK for Femoral/Tibial Shaft Fractures
Phase 2
Withdrawn
- Conditions
- Femoral Shaft FractureTibial Shaft Fracture
- Interventions
- Drug: GIK solutionDrug: Isotonic Normal Saline Solution
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 50
- Registration Number
- NCT05627479
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Phase 2
Active, not recruiting
- Conditions
- Graft Vs Host Disease
- Interventions
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 27
- Registration Number
- NCT05621759
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
Phase 2
Completed
- Conditions
- Primary Progressive Aphasia
- Interventions
- Device: Transcranial Direct Current Stimulation (tDCS)Behavioral: Word-Naming Activity
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 10
- Registration Number
- NCT05615922
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI
Active, not recruiting
- Conditions
- Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
- Interventions
- Drug: PET TracerDrug: MRI TracerDevice: 3T PET/MRI
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 30
- Registration Number
- NCT05615415
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Innate Immunity Stimulation Via TLR9 in Early AD
Phase 1
Recruiting
- Conditions
- Mild Cognitive ImpairmentAlzheimer Dementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-11-04
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 15
- Registration Number
- NCT05606341
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
Phase 1
Recruiting
- Conditions
- Type 2 DiabetesMild Cognitive Impairment
- Interventions
- Device: Continuous Glucose Monitor (CGM)
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 20
- Registration Number
- NCT05601583
- Locations
- 🇺🇸
Bellevue Hospital, New York, New York, United States
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Phase 3
Recruiting
- Conditions
- Pulmonary Embolism
- Interventions
- Drug: Anticoagulant TherapyDevice: Catheter-Directed Therapy
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 500
- Registration Number
- NCT05591118
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸Promedica, Toledo, Ohio, United States
🇺🇸Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States
Addressing Health Disparities in Chronic Low Back Pain With Patient-Clinician Relatedness
Not Applicable
Completed
- Conditions
- Chronic Low-Back Pain
- Interventions
- Other: Enhanced RelationshipOther: Limited Relationship
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 56
- Registration Number
- NCT05580380
- Locations
- 🇺🇸
New York University Department of Physical Therapy, Arthur J. Nelson Human Performance Laboratory, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath